Masakazu Abe
Hamamatsu, 4313192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Response to Letter].
Journal: Drug design, development and therapy
Published: July 30, 2026
Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone.
Journal: International journal of clinical oncology
Published: April 12, 2026
Safety of Short-T erm Low-Dose Olanzapine in Patients with Cancer and Diabetes Receiving Cisplatin-Based Chemotherapy: A Retrospective TriNetX Cohort Study.
Journal: Drug design, development and therapy
Published: April 10, 2026
Disparities in adverse event perception between patients and healthcare providers in gynaecologic anticancer therapy: results from an observational web-based study in Japan.
Journal: BMJ open
Published: February 26, 2026
A Multicenter Phase II Study on Photodynamic Therapy Using Talaporfin Sodium (ME2906) and a Semiconductor Laser (PNL6405CIN) for Intraepithelial Tumors of the Cervix.
Journal: Reproductive medicine and biology
Published: October 02, 2025
Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy.
Journal: International journal of clinical oncology
Published: May 29, 2025
Pancreatic Neuroendocrine Tumor Leading to a Diagnosis of Multiple Endocrine Neoplasia Type 1.
Journal: DEN open
Published: January 27, 2025
Usefulness of Spleen Index and Alkaline Phosphatase Level for Predicting Post-Liver Biopsy Bleeding.
Usefulness of Spleen Index and Alkaline Phosphatase Level for Predicting Post-Liver Biopsy Bleeding.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: January 05, 2025
Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.
Journal: International cancer conference journal
Published: December 08, 2024
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: September 25, 2024
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: August 01, 2024
Last Updated: 09/26/2026